Expression and Clinicopathological Significance of Notch Signaling and Cell-Fate Genes in Biliary Tract Cancer

[1]  Natalia,et al.  Cholangiocarcinoma , 2010, Surgical Challenges in the Management of Liver Disease.

[2]  M. Yaniv,et al.  Expression of the vHNF1/HNF1β homeoprotein gene during mouse organogenesis , 1999, Mechanisms of Development.

[3]  N. Probst-Hensch,et al.  Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract. , 2010, Human pathology.

[4]  L. Gresh,et al.  Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1beta. , 2002, Development.

[5]  J. Ortonne,et al.  Sox9 Is Essential for Outer Root Sheath Differentiation and the Formation of the Hair Stem Cell Compartment , 2005, Current Biology.

[6]  N. Probst-Hensch,et al.  IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas. , 2009, Human pathology.

[7]  R. Kist,et al.  Normal lung development and function after Sox9 inactivation in the respiratory epithelium , 2005, Genesis.

[8]  Tao Zhang,et al.  SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells. , 2007, Cancer research.

[9]  Paul S. Meltzer,et al.  Mutations in the human Jagged1 gene are responsible for Alagille syndrome , 1997, Nature Genetics.

[10]  Sahar Mansour,et al.  Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene , 1994, Nature.

[11]  Cristel G. Thomas,et al.  Germline hepatocyte nuclear factor 1α and 1β mutations in renal cell carcinomas , 2005 .

[12]  Raymond E. Moellering,et al.  Direct inhibition of the NOTCH transcription factor complex , 2010, Nature.

[13]  D. Gudbjartsson,et al.  Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes , 2007, Nature Genetics.

[14]  P. Mazur,et al.  Liver‐specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice , 2008, Hepatology.

[15]  R. Kageyama,et al.  The role of notch signaling in the development of intrahepatic bile ducts. , 2004, Gastroenterology.

[16]  W. Jochum,et al.  Rare PIK3CA hotspot mutations in carcinomas of the biliary tract , 2008, Genes, chromosomes & cancer.

[17]  Holger Moch,et al.  Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas , 2010, Histopathology.

[18]  Chengquan Zhao,et al.  Immunohistochemical Analysis of Sox9 in Ovarian Sertoli Cell Tumors and Other Tumors in the Differential Diagnosis , 2007, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[19]  M. Lai,et al.  Analysis of SOX9 expression in colorectal cancer. , 2008, American journal of clinical pathology.

[20]  Hans Clevers,et al.  SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes , 2004, The Journal of cell biology.

[21]  A. Sinclair,et al.  A male-specific role for SOX9 in vertebrate sex determination. , 1996, Development.

[22]  M. Toyota,et al.  Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines , 2006, British Journal of Cancer.

[23]  Alfonso Martinez Arias,et al.  Notch, a Universal Arbiter of Cell Fate Decisions , 2006, Science.

[24]  G. Gores,et al.  Inducible nitric oxide synthase up-regulates Notch-1 in mouse cholangiocytes: implications for carcinogenesis. , 2005, Gastroenterology.

[25]  B. Stanger,et al.  Notch signaling controls liver development by regulating biliary differentiation , 2009, Development.

[26]  L. Sobin,et al.  World Health Organization classification of tumors , 2000, Cancer.

[27]  P. Nair,et al.  Coexpression of Notch1 and NF-kappaB signaling pathway components in human cervical cancer progression. , 2007, Gynecologic oncology.

[28]  Philippe Blache,et al.  Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium , 2007, The Journal of cell biology.

[29]  Raphael Kopan,et al.  The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism , 2009, Cell.

[30]  J. Epstein,et al.  Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Kristin G Ardlie,et al.  Evaluation of Common Variants in the Six Known Maturity-Onset Diabetes of the Young (MODY) Genes for Association With Type 2 Diabetes , 2007, Diabetes.

[32]  Hans Clevers,et al.  SOX9 is required for the differentiation of paneth cells in the intestinal epithelium. , 2006, Gastroenterology.

[33]  M. Loda,et al.  Defining Cell Lineages in the Prostate Epithelium , 2006, Cell cycle.

[34]  Colin C. Collins,et al.  Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1 , 1997, Nature Genetics.

[35]  R. Rad,et al.  Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma , 2010, Proceedings of the National Academy of Sciences.

[36]  R. Hruban,et al.  Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. , 2003, Cancer cell.

[37]  J. Carpten,et al.  Evidence for two independent prostate cancer risk–associated loci in the HNF1B gene at 17q12 , 2008, Nature Genetics.

[38]  S. Baylin,et al.  Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[39]  F. Tronche,et al.  Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated by the transcription factor SOX9. , 2009, Gastroenterology.

[40]  Ryoichiro Kageyama,et al.  The Hes gene family: repressors and oscillators that orchestrate embryogenesis , 2007, Development.

[41]  G. Gores,et al.  Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment , 2008, Hepatology.

[42]  B. Czerniak,et al.  Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors. , 2003, Human pathology.

[43]  Cristel G. Thomas,et al.  Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas. , 2005, Human molecular genetics.

[44]  D. Ovchinnikov,et al.  Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors , 2004, Hepatology.

[45]  N. Probst-Hensch,et al.  Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas , 2009, Hepatology.

[46]  V. Yajnik,et al.  Pathology and genetics of tumors of the digestive system , 2001 .

[47]  J. Xu,et al.  Analysis of SOX 9 Expression in Colorectal Cancer , 2008 .

[48]  P. Majumder,et al.  Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma. , 2009, Gastroenterology.

[49]  W. Willett,et al.  Multiple loci identified in a genome-wide association study of prostate cancer , 2008, Nature Genetics.

[50]  P. Mazur,et al.  Identification of Epidermal Pdx1 Expression Discloses Different Roles of Notch1 and Notch2 in Murine KrasG12D-Induced Skin Carcinogenesis In Vivo , 2010, PloS one.

[51]  P N Goodfellow,et al.  SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene , 1997, Molecular and cellular biology.

[52]  Arie Perry,et al.  Notch1 and Notch2 Have Opposite Effects on Embryonal Brain Tumor Growth , 2004, Cancer Research.

[53]  Tao Zhang,et al.  SOX 9 Is Expressed in Normal Prostate Basal Cells and Regulates Androgen Receptor Expression in Prostate Cancer Cells , 2007 .